SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 214 filers reported holding SAGE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,116 | -56.2% | 200 | 0.0% | 0.00% | -60.0% |
| Q2 2023 | $9,404 | +12.1% | 200 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $8,392 | +10.0% | 200 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $7,628 | -4.6% | 200 | 0.0% | 0.01% | -16.7% |
| Q3 2022 | $8,000 | +33.3% | 200 | 0.0% | 0.01% | +50.0% |
| Q2 2022 | $6,000 | -14.3% | 200 | 0.0% | 0.00% | -20.0% |
| Q1 2022 | $7,000 | -22.2% | 200 | 0.0% | 0.01% | -16.7% |
| Q4 2021 | $9,000 | 0.0% | 200 | 0.0% | 0.01% | -14.3% |
| Q3 2021 | $9,000 | -18.2% | 200 | 0.0% | 0.01% | -22.2% |
| Q2 2021 | $11,000 | -26.7% | 200 | 0.0% | 0.01% | -30.8% |
| Q1 2021 | $15,000 | -11.8% | 200 | 0.0% | 0.01% | -23.5% |
| Q4 2020 | $17,000 | – | 200 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 475,600 | $15,362,000 | 5.31% |
| Integral Health Asset Management, LLC | 412,257 | $13,316,000 | 2.74% |
| Palo Alto Investors LP | 851,409 | $27,501,000 | 2.40% |
| Boxer Capital, LLC | 1,094,000 | $35,336,000 | 2.24% |
| DAFNA Capital Management LLC | 180,306 | $5,824,000 | 1.59% |
| Ikarian Capital, LLC | 250,000 | $8,075,000 | 1.47% |
| Bellevue Group AG | 2,973,178 | $96,034,000 | 1.36% |
| SECTOR GAMMA AS | 118,476 | $3,827,000 | 0.86% |
| Artal Group S.A. | 450,000 | $14,535,000 | 0.78% |
| Diametric Capital, LP | 19,393 | $626,000 | 0.46% |